Challenging Cases in Patient Safety: The Nation’s Experience Navigating New Technologies as Told to RO-ILS

When implementing newer technologies practices often rely on vendor training, an evaluation of published literature, and collaboration with others experienced in the technology. Incident learning has a critical role in radiation therapy and may be most important in new and emerging technologies. RO-ILS: Radiation Oncology Incident Learning System® can share the de-identified experiences of practices across the country with the community, including practices who may only just be considering implementing these technologies. Incident learning data is a unique mechanism to supplement prospective risk analysis by collating challenges and lessons learned from others. Presentations by the RO-ILS advisory council of RO-ILS data is an important mechanism to share anonymized real-world data and experience with the community, especially critical in the areas of emerging technology. Attendees learn how to approach challenging scenarios to ensure safe and consistent treatment delivery, filling the knowledge gap of how to approach these new technologies and build robust systems around their initial implementation.

The practice of radiation oncology is constantly evolving. Newer technologies such as MR-guided radiation therapy, online adaptive radiation therapy, and autocontouring have been gaining wider adoption. Additionally, practices must navigate the challenges of acquiring new equipment, transitioning to new software, or updating existing software. To safely accomplish these advances, practices must develop comprehensive educational plans and operating procedures. Lessons learned from incident learning often provide important insight for practices to optimize patient safety. An expert panel focuses on difficult to manage safety issues in the latest era of radiation oncology as seen in RO-ILS: Radiation Oncology Incident Learning System® events. Members of the Radiation Oncology Healthcare Advisory Council (RO-HAC) share de-identified RO-ILS data and cases on the theme of new technology, either new to the field or field to the practice. A multidisciplinary panel of RO-HAC members and RO-ILS users discuss considerations in how they would approach such safety events and associated themes. Participants receive an enhanced understanding of how to approach errors reported from across the country and have practical ways to implement process changes in their clinics to improve patient safety.

Topics:

  1. Introduction
    Bill J. Salter, PhD
  2. MR-guided Radiation Therapy (MRgRT): Case Presentations 
    Ann Raldow, MD, MPH
  3. Online Adaptive Pitfalls as Told to RO-ILS
    Jeffrey R. Olsen, MD
  4. Automated Contouring
    Bill J. Salter, PhD
  5. Implementing New Technology in Radiation Oncology
    Timothy D. Shafman, MD
  6. Q and A
    Full Panel

This activity is available from May 28, 2024, through 11:59 p.m. Eastern time on May 27, 2026. 

This activity was originally recorded at the 2023 ASTRO Annual Meeting.

Target Audience

The activity is designed to meet the interests of radiation oncologists, physicists, radiation therapists, dosimetrists, and residents.  

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify risk assessment tools to reduce safety concerns when implementing new technology.
  • Determine ways of leveraging benefits and mitigating risk when bringing new technology into the clinic with minimal on-site experience with this new technology.
  • Discuss ways in which to leverage RO-ILS and incident learning with new technology. 
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.
Course opens: 
05/28/2024
Course expires: 
05/27/2026
Cost:
$0.00
Rating: 
0
  • Bill J. Salter, PhD, is employed by the Huntsman Cancer Institute - University of Utah. Dr. Salter receives honoraria from Clarity PSO and Mevion Medical System. Dr. Salter receives grant/research funding from RaySearch Labs, Elekta Clarit, and the University of Utah. Dr. Salter serves as a committee member with ASTRO, AAPM, ACR (Economic committee), University of Utah (CORI committee Co-Leader), and Varian (Intelligent Imaging Consortium).   
  • Ann Raldow, MD, MPH, is employed by University of California, Los Angeles. Dr. Raldow receives compensation from ViewRay, Inc. for service as a consultant. Dr. Raldow receives grant/research funding from BlueHalo (formerly Intelligent Automation, Inc.). 
  • Jeffrey R. Olsen, MD, is employed by Memorial Hospital and the University of Colorado School of Medicine. Dr. Olsen receives compensation from Syntactx. Dr. Olsen receives honoraria from IJROBP, the Veteran's Health Administration's Rectal Cancer Blue Ribbon Panel, and serves on the ASTRO Radiation Oncology Healthcare Advisory Council. Dr. Olsen is a consultant for the NAMSA clinical events committee. 
  • Timothy D. Shafman, MD, is employed by GenesisCare USA.

The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.

Price

Cost:
$0.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.

Nonmember: $149
Member: $99
Member-in-training: $49
Student/Grad Student/PGY: $49
Postdoctoral Fellow: $49
 

Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.

Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.

The course and its materials will only be available on the ASTRO website until May 27, 2026, regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.